The Valley Desk

NCT00245622 · Interventional trial

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

Overall registry status Completed

Phase 2

Conditions Relapsing-Remitting Multiple Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov